PEN — Penumbra Inc. stock price and chart

Share this page

PEN

$317.55-0.14%

as of close, Oct 2, 2026

☾ AH $317.55 -0.14%

Penumbra Inc.Stock · Health CareRussell 1000 0.02%Russell 3000 0.02%US Stock Market 0.02%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

100.0150.0200.0250.0300.0350.0010.0M20.0M$317.55

2026-10-02

Price$317.55

MA20$321.18

MA50$305.59

Vol1.6M

What would $1,000 invested in PEN be worth today? →

PEN returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $317.55
Change YTD: +2.14%
Next earnings: Nov 4, 2026
Market cap: 12.5B2016-12 2B2026-10 12.5B+519.6% over the window
Enterprise value: 12.5B
Shares outstanding: 39.4M2016-06 31.1M2026-06 39.4M+26.8% over the window
52W low: $221.26
52W high: $362.41
From 52W high: -12.38%
From 52W low: +43.52%
52W range: 68%
Beta: 0.70

Volume

Rel volume: 0.68×
30D volume: 352.9K
30D $ vol: 112.9M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3MNo open-market insider purchase or sale with a transaction date in the last 91 days, as filed on Form 4.: none
Insider net 1Y0 insider-days of buying (no priced lot) and 4 of selling ($981K) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$981K

Form 4 transactions by trade date, as filed; latest on file 2026-04-02.

Fundamentals

Sales (ttm): 1.5B2016-06 227.9M2026-06 1.5B+560.4% over the window
Sales/share: $38.212016-06 $7.342026-06 $38.21+420.7% over the window
EPS (ttm): $4.072016-06 $0.242026-06 $4.07+1595.8% over the window
FCF (ttm): 215.9M2016-06 -26.6M2026-06 215.9M-910.6% over the window
FCF/share: $5.482016-06 -$0.862026-06 $5.48-739.1% over the window
Book value/share: $38.862016-06 $7.972026-06 $38.86+387.5% over the window
Net margin: 10.67%2016-06 3.4%2026-06 10.7%+210.2% over the window
ROE: 10.49%2016-06 3.2%2026-06 10.5%+231.3% over the window
ROA: 8.13%2016-06 2.8%2026-06 8.1%+194.6% over the window
Current ratio: 5.752016-06 8.082026-06 5.75-28.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +17.57%2025-06-30 → 2026-06-301.3B → 1.5B (+17.6% total)+17.07%2023-06-30 → 2026-06-30937.8M → 1.5B (+60.5% total)+17.52%2021-06-30 → 2026-06-30671.4M → 1.5B (+124.1% total)+20.78%2016-06-30 → 2026-06-30227.9M → 1.5B (+560.4% total)
Net income: +8.73%2025-06-30 → 2026-06-30147.7M → 160.6M (+8.7% total)+76.64%2023-06-30 → 2026-06-3029.1M → 160.6M (+451.3% total)+58.81%2021-06-30 → 2026-06-3015.9M → 160.6M (+910.0% total)+35.26%2016-06-30 → 2026-06-307.8M → 160.6M (+1948.9% total)
FCF: +33.61%2025-06-30 → 2026-06-30161.6M → 215.9M (+33.6% total)+650.52%2023-06-30 → 2026-06-30510K → 215.9M (+42234.5% total)n/an/a
Shares: +1.00%2025-06-30 → 2026-06-3039M → 39.4M (+1.0% total)+0.82%2023-06-30 → 2026-06-3038.4M → 39.4M (+2.5% total)+1.49%2021-06-30 → 2026-06-3036.6M → 39.4M (+7.7% total)+2.41%2016-06-30 → 2026-06-3031.1M → 39.4M (+26.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +9.22%2025-06-30 → 2026-06-30$3.73 → $4.07 (+9.2% total)+76.49%2023-06-30 → 2026-06-30$0.74 → $4.07 (+450.0% total)+56.76%2021-06-30 → 2026-06-30$0.43 → $4.07 (+846.5% total)+32.73%2016-06-30 → 2026-06-30$0.24 → $4.07 (+1595.8% total)
Sales/share: +16.40%2025-06-30 → 2026-06-30$32.83 → $38.21 (+16.4% total)+16.12%2023-06-30 → 2026-06-30$24.40 → $38.21 (+56.6% total)+15.79%2021-06-30 → 2026-06-30$18.36 → $38.21 (+108.1% total)+17.94%2016-06-30 → 2026-06-30$7.34 → $38.21 (+420.7% total)
FCF/share: +32.29%2025-06-30 → 2026-06-30$4.14 → $5.48 (+32.3% total)+644.43%2023-06-30 → 2026-06-30$0.01 → $5.48 (+41210.5% total)n/an/a
Book value/share: +17.14%2025-06-30 → 2026-06-30$33.18 → $38.86 (+17.1% total)+11.88%2023-06-30 → 2026-06-30$27.75 → $38.86 (+40.1% total)+16.12%2021-06-30 → 2026-06-30$18.41 → $38.86 (+111.1% total)+17.17%2016-06-30 → 2026-06-30$7.97 → $38.86 (+387.5% total)
Price: +25.29%2025-10-02 → 2026-10-02$253.49 → $317.55 (+25.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.99%2023-10-02 → 2026-10-02$238.63 → $317.55 (+33.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.83%2021-10-01 → 2026-10-02$263.09 → $317.55 (+20.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.37%2016-09-30 → 2026-10-02$75.99 → $317.55 (+317.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +25.29%2025-10-02 → 2026-10-02$253.49 → $317.55 (+25.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.99%2023-10-02 → 2026-10-02$238.63 → $317.55 (+33.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.83%2021-10-01 → 2026-10-02$263.09 → $317.55 (+20.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.37%2016-09-30 → 2026-10-02$75.99 → $317.55 (+317.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 78.0×2016-12 107.142026-10 77.89-27.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 66.8×2016-12 1244.682026-10 66.77-94.6% over the window
Fwd P/E: 51.9×
P/S (ttm)Market cap ÷ TTM revenue.: 8.3×2016-12 8.252026-10 8.31+0.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 8.2×2016-12 7.662026-10 8.17+6.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 57.9×2016-12 -101.912026-10 57.93-156.8% over the window
EV/EBITDA (fy): 61.2×
EV/Sales (ttm): 8.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 1.73%2016-09 -1.0%2026-06 1.7%-276.9% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 39.4M ÷ 39.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.00%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.00%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($10B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.00%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($12.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($12.5B). Same caveat as the cash buyback yield.: 0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/E: 13th
P/OI: 8th
P/S: 19th
P/B: 29th
P/FCF: 3rd

Bar = where today’s multiple sits in PEN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-02

-0.14%

-0.42%

-1.63%

-0.32%

YTD

+2.14%

+25.27%

+20.70%

Recent filings

Jul 30Earnings · Earnings release — EPS $0.88 vs $1.15 est. (−23.5%); revenue $390.0M (+15% y/y) 0.4%
Jul 30Report · Quarterly report, Q2 2026 — revenue $390.0M (+15% y/y), net income $34.8M, EPS $0.88
Jun 228-K · Shareholder vote results

All filings and insider trades →

Financial statements

Open full PEN financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-13.21%	-0.04%
NVO	Novo Nordisk A/S	-20.21%	-0.21%
SNY	Sanofi ADS	-10.23%	-1.84%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-6.76%	-0.32%
NTRA	Natera Inc.	+26.20%	+0.46%
ARGX	argenx SE American Depositary Shares	-12.90%	-1.79%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	-3.09%	+0.00%
TEVA	Teva Pharmaceutical Industries Limited American Depositary Shares	+5.44%	+0.56%

PEN — Penumbra Inc. price, chart and key statistics